Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 6;11(7):1046.
doi: 10.3390/healthcare11071046.

Pharmacological Modulation of Temporal Discounting: A Systematic Review

Affiliations
Review

Pharmacological Modulation of Temporal Discounting: A Systematic Review

Luis Felipe Sarmiento et al. Healthcare (Basel). .

Abstract

Temporal discounting is a phenomenon where a reward loses its value as a function of time (e.g., a reward is more valuable immediately than when it delays in time). This is a type of intertemporal decision-making that has an association with impulsivity and self-control. Many pathologies exhibit higher discounting rates, meaning they discount more the values of rewards, such as addictive behaviors, bipolar disorder, attention-deficit/hyperactivity disorders, social anxiety disorders, and major depressive disorder, among others; thus, many studies look for the mechanism and neuromodulators of these decisions. This systematic review aims to investigate the association between pharmacological administration and changes in temporal discounting. A search was conducted in PubMed, Scopus, Web of Science, Science Direct and Cochrane. We used the PICO strategy: healthy humans (P-Participants) that received a pharmacological administration (I-Intervention) and the absence of a pharmacological administration or placebo (C-Comparison) to analyze the relationship between the pharmacological administration and the temporal discounting (O-outcome). Nineteen studies fulfilled the inclusion criteria. The most important findings were the involvement of dopamine modulation in a U-shape for choosing the delayed outcome (metoclopradime, haloperidol, and amisulpride). Furthermore, administration of tolcapone and high doses of d-amphetamine produced a preference for the delayed option. There was a time-dependent hydrocortisone effect in the preference for the immediate reward. Thus, it can be concluded that dopamine is a crucial modulator for temporal discounting, especially the D2 receptor, and cortisol also has an important time-dependent role in this type of decision. One of the limitations of this systematic review is the heterogeneity of the drugs used to assess the effect of temporal discounting.

Keywords: decision-making; drug administration; impulsivity; intertemporal decisions; self-control; temporal discounting.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Hyperbolic Discounting. Note. The discounting of the outcome has a hyperbolic shape in function of time. The continuous line represents the hyperbolic function, and the dotted line an exponential function.
Figure 2
Figure 2
Prisma Flowchart. Note. Adapted PRISMA flow diagram of the study selection.
Figure 3
Figure 3
Analysis of Risk of bias. Note. Risk of bias using the Rob 2.0 tool for the 19 selected studies [2,13,22,25,26,27,28,29,30,31,32,33,34,35,36,38,39,41,42] (Risk +, ?, −), and the domains evaluated.

References

    1. Kalenscher T., Pennartz C.M. Is a bird in the hand worth two in the future? The neuroeconomics of intertemporal decision-making. Prog. Neurobiol. 2008;84:284–315. doi: 10.1016/j.pneurobio.2007.11.004. - DOI - PubMed
    1. Riis-Vestergaard M.I., van Ast V., Cornelisse S., Joëls M., Haushofer J. The effect of hydrocortisone administration on intertemporal choice. Psychoneuroendocrinology. 2018;88:173–182. doi: 10.1016/j.psyneuen.2017.10.002. - DOI - PubMed
    1. Haushofer J., Jain P., Musau A., Ndetei D. Stress May Increase Choice of Sooner Outcomes, But Not Temporal Discounting. J. Econ. Behav. Organ. 2021;183:377–396. doi: 10.1016/j.jebo.2020.12.024. - DOI
    1. Madden G.J., Petry N.M., Johnson P.S. Pathological gamblers discount probabilistic rewards less steeply than matched controls. Exp. Clin. Psychopharmacol. 2009;17:283–290. doi: 10.1037/a0016806. - DOI - PMC - PubMed
    1. Scheres A., Tontsch C., Thoeny A.L., Kaczkurkin A. Temporal reward discounting in attention-deficit/hyperactivity disorder: The contribution of symptom domains, reward magnitude, and session length. Biol. Psychiatry. 2010;67:641–648. doi: 10.1016/j.biopsych.2009.10.033. - DOI - PubMed

LinkOut - more resources